Filter

Refine by collections

Refine by date

—
  • Print
  • Save

Search Results

You are looking at 11 - 17 of 17 items for :

  • "empagliflozin" x
Clear All
Jyotsna S Jagai Division of Environmental and Occupational Health Sciences, School of Public Health, University of Illinois at Chicago, Chicago, Illinois, USA

Search for other papers by Jyotsna S Jagai in
Google Scholar
PubMed Close
,
Alison K Krajewski Oak Ridge Institute for Science and Education, U.S. Environmental Protection Agency, Center for Public Health and Environmental Assessment, Public Health and Environmental Systems Division, Chapel Hill, North Carolina, USA
U.S. Environmental Protection Agency, Center for Public Health and Environmental Assessment, Research Triangle Park, North Carolina, USA

Search for other papers by Alison K Krajewski in
Google Scholar
PubMed Close
,
Kyla N Price Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA

Search for other papers by Kyla N Price in
Google Scholar
PubMed Close
,
Danelle T Lobdell U.S. Environmental Protection Agency, Center for Public Health and Environmental Assessment, Research Triangle Park, North Carolina, USA

Search for other papers by Danelle T Lobdell in
Google Scholar
PubMed Close
, and
Robert M Sargis Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA

Search for other papers by Robert M Sargis in
Google Scholar
PubMed Close

D Bluhmki E Hantel S Mattheus M Devins T Johansen OE Woerle HJ et al . Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes . New England Journal of Medicine 2015 373 2117 – 2128 . ( https://doi.org/10

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-21-0132
Volume/Issue:
Volume 10: Issue 9
Open access
Adrian F Daly Department of Endocrinology, Centre Hospitalier Universitaire (CHU) de Liège, Liège Université, Domaine Universitaire du Sart-Tilman, Liège, Belgium

Search for other papers by Adrian F Daly in
Google Scholar
PubMed Close
,
Liliya Rostomyan Department of Endocrinology, Centre Hospitalier Universitaire (CHU) de Liège, Liège Université, Domaine Universitaire du Sart-Tilman, Liège, Belgium

Search for other papers by Liliya Rostomyan in
Google Scholar
PubMed Close
,
Daniela Betea Department of Endocrinology, Centre Hospitalier Universitaire (CHU) de Liège, Liège Université, Domaine Universitaire du Sart-Tilman, Liège, Belgium

Search for other papers by Daniela Betea in
Google Scholar
PubMed Close
,
Jean-François Bonneville Department of Endocrinology, Centre Hospitalier Universitaire (CHU) de Liège, Liège Université, Domaine Universitaire du Sart-Tilman, Liège, Belgium

Search for other papers by Jean-François Bonneville in
Google Scholar
PubMed Close
,
Chiara Villa Department of Endocrinology, Centre Hospitalier Universitaire (CHU) de Liège, Liège Université, Domaine Universitaire du Sart-Tilman, Liège, Belgium
Department of Pathological Cytology and Anatomy, Foch Hospital, Paris, France

Search for other papers by Chiara Villa in
Google Scholar
PubMed Close
,
Natalia S Pellegata Institute for Diabetes and Cancer, Helmholtz Zentrum München, Neuherberg, Germany

Search for other papers by Natalia S Pellegata in
Google Scholar
PubMed Close
,
Beatrice Waser Division of Cell Biology and Experimental Cancer Research, Institute of Pathology, University of Bern, Bern, Switzerland

Search for other papers by Beatrice Waser in
Google Scholar
PubMed Close
,
Jean-Claude Reubi Division of Cell Biology and Experimental Cancer Research, Institute of Pathology, University of Bern, Bern, Switzerland

Search for other papers by Jean-Claude Reubi in
Google Scholar
PubMed Close
,
Catherine Waeber Stephan Clinique Générale Ste-Anne, Fribourg, Switzerland

Search for other papers by Catherine Waeber Stephan in
Google Scholar
PubMed Close
,
Emanuel Christ Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel, University of Basel, Basel, Switzerland

Search for other papers by Emanuel Christ in
Google Scholar
PubMed Close
, and
Albert Beckers Department of Endocrinology, Centre Hospitalier Universitaire (CHU) de Liège, Liège Université, Domaine Universitaire du Sart-Tilman, Liège, Belgium

Search for other papers by Albert Beckers in
Google Scholar
PubMed Close

difficult to control (HbA1c: 9.2%) on multiple therapies (dulaglutide, metformin, empagliflozin and gliclazide); she had ongoing problems with obesity (bariatric surgery was planned) and a diagnosis of non-alcoholic steatohepatitis (NASH) was established

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-19-0004
Volume/Issue:
Volume 8: Issue 4
Open access
Christine Rode Andreasen Steno Diabetes Center Copenhagen, Gentofte, Denmark
Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark

Search for other papers by Christine Rode Andreasen in
Google Scholar
PubMed Close
,
Andreas Andersen Steno Diabetes Center Copenhagen, Gentofte, Denmark
Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark

Search for other papers by Andreas Andersen in
Google Scholar
PubMed Close
,
Filip Krag Knop Steno Diabetes Center Copenhagen, Gentofte, Denmark
Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Filip Krag Knop in
Google Scholar
PubMed Close
, and
Tina Vilsbøll Steno Diabetes Center Copenhagen, Gentofte, Denmark
Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Tina Vilsbøll in
Google Scholar
PubMed Close

reduction in the inflammatory marker C-reactive protein compared to the sodium-glucose co-transporter-2 inhibitor (SGLT-2i) empagliflozin, without any difference in reduction in body weight between compounds ( 28 ). Findings from animal studies suggest that

Article Type:
Review Article
DOI:
https://doi.org/10.1530/EC-21-0130
Volume/Issue:
Volume 10: Issue 7
Open access
Peter Wolf Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria

Search for other papers by Peter Wolf in
Google Scholar
PubMed Close
,
Yvonne Winhofer Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria

Search for other papers by Yvonne Winhofer in
Google Scholar
PubMed Close
,
Martin Krššák Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria
High Field MR Centre, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria

Search for other papers by Martin Krššák in
Google Scholar
PubMed Close
, and
Michael Krebs Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria

Search for other papers by Michael Krebs in
Google Scholar
PubMed Close

-1820 ) 85 Zinman B Wanner C Lachin JM Fitchett D Bluhmki E Hantel S Mattheus M Devins T Johansen OE Woerle HJ Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes . New England Journal of Medicine

Article Type:
Review Article
DOI:
https://doi.org/10.1530/EC-17-0031
Volume/Issue:
Volume 6: Issue 4
Open access
Wenrui Wang Department of Endocrinology, The Second Hospital of Jilin University, Changchun, People’s Republic of China

Search for other papers by Wenrui Wang in
Google Scholar
PubMed Close
and
Chuan Zhang Department of Endocrinology, The Second Hospital of Jilin University, Changchun, People’s Republic of China

Search for other papers by Chuan Zhang in
Google Scholar
PubMed Close

– 2862 . ( https://doi.org/10.2337/db09-0685 ) 89 Ojima A Matsui T Nishino Y Nakamura N Yamagishi S . Empagliflozin, an inhibitor of sodium-glucose cotransporter 2 exerts anti-inflammatory and antifibrotic effects on experimental diabetic

Article Type:
Review Article
DOI:
https://doi.org/10.1530/EC-21-0260
Volume/Issue:
Volume 10: Issue 8
Open access
David Koeckerling Medical Sciences Division, University of Oxford, Oxford, UK

Search for other papers by David Koeckerling in
Google Scholar
PubMed Close
,
Jeremy W Tomlinson Oxford Centre for Diabetes, Endocrinology & Metabolism, University of Oxford, Oxford, UK

Search for other papers by Jeremy W Tomlinson in
Google Scholar
PubMed Close
, and
Jeremy F Cobbold Oxford Liver Unit, NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK

Search for other papers by Jeremy F Cobbold in
Google Scholar
PubMed Close

Devins T Johansen OE Woerle HJ , Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes . New England Journal of Medicine 2015 373 2117 – 2128 . ( https://doi.org/10.1056/NEJMoa1504720 ) 95 Hayashizaki-Someya Y

Article Type:
Review Article
DOI:
https://doi.org/10.1530/EC-20-0174
Volume/Issue:
Volume 9: Issue 7
Open access
Qian Deng Graduate College of Anhui University of Chinese Medicine, Hefei, China

Search for other papers by Qian Deng in
Google Scholar
PubMed Close
,
Yue Zhu Graduate College of Anhui University of Chinese Medicine, Hefei, China

Search for other papers by Yue Zhu in
Google Scholar
PubMed Close
,
Mengmeng Zhang Graduate College of Anhui University of Chinese Medicine, Hefei, China

Search for other papers by Mengmeng Zhang in
Google Scholar
PubMed Close
,
Aihua Fei Department of Endocrinology, The Second Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China

Search for other papers by Aihua Fei in
Google Scholar
PubMed Close
,
Jiaqi Liang Graduate College of Anhui University of Chinese Medicine, Hefei, China

Search for other papers by Jiaqi Liang in
Google Scholar
PubMed Close
,
Jinjin Zheng Graduate College of Anhui University of Chinese Medicine, Hefei, China

Search for other papers by Jinjin Zheng in
Google Scholar
PubMed Close
,
Qingping Zhang College of Acupuncture-moxibustion and Tuina, Anhui University of Chinese Medicine, Hefei, China

Search for other papers by Qingping Zhang in
Google Scholar
PubMed Close
,
Tong Cheng Department of Geriatrics, Zhongshan Hospital, Fudan University, Shanghai, China

Search for other papers by Tong Cheng in
Google Scholar
PubMed Close
, and
Xia Ge Department of Endocrinology, The Second Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China

Search for other papers by Xia Ge in
Google Scholar
PubMed Close

therapeutic implications . Heart Failure Clinics 2019 15 341 – 347 . ( https://doi.org/10.1016/j.hfc.2019.02.003 ) 63 Zhou H Wang S Zhu P Hu S Chen Y Ren J . Empagliflozin rescues diabetic myocardial microvascular injury via AMPK

Article Type:
Review Article
Collections:
Metabolic Syndrome and Diabetes
DOI:
https://doi.org/10.1530/EC-22-0419
Volume/Issue:
Volume 12: Issue 3
Open access